CTHRC1 Is a Prognostic Biomarker and Correlated With Immune Infiltrates in Kidney Renal Papillary Cell Carcinoma and Kidney Renal Clear Cell Carcinoma

被引:19
|
作者
Zhou, Fenfang [1 ]
Shen, Dexin [1 ]
Xiong, Yaoyi [1 ]
Cheng, Songtao [1 ]
Xu, Huimin [1 ]
Wang, Gang [2 ,3 ,4 ]
Qian, Kaiyu [2 ,3 ,4 ]
Ju, Lingao [2 ,3 ]
Zhang, Xinhua [1 ]
机构
[1] Wuhan Univ, Dept Urol, Zhongnan Hosp, Wuhan, Peoples R China
[2] Wuhan Univ, Dept Biol Repositories, Zhongnan Hosp, Wuhan, Peoples R China
[3] Human Genet Resource Preservat Ctr Hubei Prov, Wuhan, Peoples R China
[4] Wuhan Univ, Lab Precis Med, Zhongnan Hosp, Wuhan, Peoples R China
来源
FRONTIERS IN ONCOLOGY | 2021年 / 10卷
基金
中国国家自然科学基金;
关键词
collagen triple helix repeat containing 1 (CTHRC1); kidney renal clear cell carcinoma; kidney renal papillary cell carcinoma; prognosis; immune infiltration;
D O I
10.3389/fonc.2020.570819
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Kidney renal clear cell carcinoma (KIRC) and kidney renal papillary cell carcinoma (KIRP) are the most common RCC types. RCC has high immune infiltration levels, and immunotherapy is currently one of the most promising treatments for RCC. Collagen triple helix repeat containing 1 (CTHRC1) is an extracellular matrix protein that regulates tumor invasion and modulates the tumor microenvironment. However, the association of CTHRC1 with the prognosis and tumor-infiltrating lymphocytes of KIRP and KIRC has not been reported. We examined the CTHRC1 expression differences in multiple tumor tissues and normal tissues via exploring TIMER, Oncomine, and UALCAN databases. Then, we searched the Kaplan-Meier plotter database to evaluate the correlation of CTHRC1 mRNA level with clinical outcomes. Subsequently, the TIMER platform and TISIDB website were chosen to assess the correlation of CTHRC1 with tumor immune cell infiltration level. We further explored the causes of aberrant CTHRC1 expression in tumorigenesis. We found that CTHRC1 level was significantly elevated in KIRP and KIRC tissues relative to normal tissues. CTHRC1 expression associates with tumor stage, histology, lymph node metastasis, and poor clinical prognosis in KIRP. The CTHRC1 level correlates to tumor grade, stage, nodal metastasis, and worse survival prognosis. Additionally, CTHRC1 is positively related to different tumor-infiltrating immune cells in KIRP and KIRC. Moreover, CTHRC1 was closely correlated with the gene markers of diverse immune cells. Also, high CTHRC1 expression predicted a worse prognosis in KIRP and KIRC based on immune cells. Copy number variations (CNV) and DNA methylation might contribute to the abnormal upregulation of CTHRC1 in KIRP and KIRC. In conclusion, CTHRC1 can serve as a biomarker to predict the prognosis and immune infiltration in KIRP and KIRC.
引用
收藏
页数:14
相关论文
共 50 条
  • [21] DNA methylation of Hugl-2 is a prognostic biomarker in kidney renal clear cell carcinoma
    Miao, Yi
    Cao, Fang
    Li, Pingping
    Liu, Peijun
    CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2021, 48 (01) : 44 - 53
  • [22] Hepcidin as a prognostic biomarker in clear cell renal cell carcinoma
    Zhou, Zijian
    Wu, Jiajin
    Yang, Yuanyuan
    Gao, Peng
    Wang, Lujia
    Wu, Zhong
    AMERICAN JOURNAL OF CANCER RESEARCH, 2022, 12 (09): : 4120 - +
  • [23] TACC3 is a prognostic biomarker for kidney renal clear cell carcinoma and correlates with immune cell infiltration and T cell exhaustion
    Fan, Xiaoyan
    Liu, Boyi
    Wang, Zhiyu
    He, Dongwei
    AGING-US, 2021, 13 (06): : 8541 - 8562
  • [24] OCLN as a novel biomarker for prognosis and immune infiltrates in kidney renal clear cell carcinoma: an integrative computational and experimental characterization
    Jia, Zongming
    Kong, Ying
    Wang, Chengyu
    Fu, Zhenyu
    Tian, Zhen
    Sun, Yizhang
    Lin, Yuxin
    Huang, Yuhua
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [25] ARPC1B is a novel prognostic biomarker for kidney renal clear cell carcinoma and correlates with immune infiltration
    Tang, Yong-Fei
    Qiao, Bin
    Huang, Ya-Bing
    Wang, Ming
    FRONTIERS IN MOLECULAR BIOSCIENCES, 2023, 10
  • [26] A novel prognostic signature of chemokines for survival and immune infiltration in kidney renal clear cell carcinoma
    Weng, Jianming
    Huang, Zhiyong
    Li, Qiang
    Huang, Yuzhen
    Chen, Shunping
    INTERNATIONAL JOURNAL OF MEDICAL SCIENCES, 2023, 20 (08): : 1046 - 1059
  • [27] PAQR6 as a prognostic biomarker and potential therapeutic target in kidney renal clear cell carcinoma
    Zou, Tao
    Jia, Zongming
    Wu, Jixiang
    Liu, Xuxu
    Deng, Minghao
    Zhang, Xuefeng
    Lin, Yuxin
    Ping, Jigen
    FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [28] Low expression of PRRG2 in kidney renal clear cell carcinoma: an immune infiltration-associated prognostic biomarker
    Gonglin Tang
    Guixin Ding
    Gang Wu
    Xiaofeng Wang
    Tianqi Wang
    Qingsong Zou
    Kai Sun
    Jitao Wu
    Discover Oncology, 15
  • [29] Low expression of PRRG2 in kidney renal clear cell carcinoma: an immune infiltration-associated prognostic biomarker
    Tang, Gonglin
    Ding, Guixin
    Wu, Gang
    Wang, Xiaofeng
    Wang, Tianqi
    Zou, Qingsong
    Sun, Kai
    Wu, Jitao
    DISCOVER ONCOLOGY, 2024, 15 (01)
  • [30] Glia Maturation Factor β as a Novel Independent Prognostic Biomarker and Potential Therapeutic Target of Kidney Renal Clear Cell Carcinoma
    Zhu, Tong
    Wang, Tianyu
    Feng, Zijun
    Gao, Furong
    Zhang, Jieping
    Jin, Caixia
    Tian, Haibin
    Xu, Jingying
    Chen, Hao
    Ou, Qingjian
    Wang, Juan
    Xu, Guotong
    Lu, Lixia
    FRONTIERS IN ONCOLOGY, 2022, 12